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ABSTRACT 
Gastroretentive microspheres of clarithromycin were prepared on the principle of cation induced gelification using sodium alginate 
and pectin. These microspheres were investigated for micromeritic properties, drug entrapment, mucoadhesion and drug release 
properties. Microspheres were found to be discrete, spherical and free flowing. Microspheres were found to adhere to gastric mucosa 
with high affinity and showed controlled drug release. 
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INTRODUCTION:  
H. pylorus infects approximately 50% of the adult 
formulation; is associated with a wide range of upper 
gastrointestinal diseases like peptic ulcer and gastric 
cancer. The widely used  drugs for the eradication of H. 
pylori failed to treat the disease fully, might be due to 
the fact that the drug does not remain in the stomach  for 
long period and do not attain minimum inhibitory 
concentration in the gastric mucosa. Stomach speciﬁc 
drug delivery systems can prolong the residence time of 
drug in the stomach, thereby continuously release the 
drug in the infected area. Mucoadhesive dosage forms 
have been widely used for site-speciﬁc targeting for both 
local and systemic drug delivery and have also been 
beneﬁcial for the treatment of H. pylori infection. 
Mucoadhesion involves strong interaction between 
polymer and mucus lining of the tissue which increases 
contact time, permits localization, and prolongs drug 
absorption. 
MATERIALS AND METHODS: 
 Clarithromycin (CLA) was obtained from Alkem labs. 
(Daman, India) as gift sample. Sodium Alginate and 
Pectin were procurred of Loba chemie Pvt. Ltd., 
Mumbai brand (LR grade). 
Preparation of Microspheres 
Microspheres were prepared employing method of 
Rajaonarivony et al. with some modification on the 
principle of cation-induced gelification. Aqueous 
dispersions of sodium alginate and Pectin were prepared 
in varying ratio of 1:1, 2:1, 3:1, 2:1, 2:2, 2:3, 3:1, 3:2, 
3:3 respectively with proper mixing on magnetic stirrer. 
Clarithromycin 250 mg was added in polymeric 
dispersion with continuous stirring for 5 minutes. 
Calcium chloride (1 mL, 18 mmol L
-1
) was added into 
20 mL of the above drug polymer dispersion followed 
by stirring for 30-45 minutes. The microspheres so 
prepared were collected by decantation technique, 
washed repeatedly with deionized water and dried at 
45
0
C for 12 hr
1
.  
Characterization of Microspheres 
Surface morphology of the microspheres was done using 
scanning electron microscopy (SEM) (Joel 6100, Japan). 
All microsphere formulations were sprinkled on a 
double adhesive tape, which was previously stuck to an 
aluminum stub. The stubs were coated with gold up to a 
thickness of about 300 Å under an argon atmosphere 
using a gold sputter module in a high-vacuum 
evaporator. Prepared samples were randomly scanned 
and photomicrographs were obtained using electron 
microscope. Compressibility and flow properties were 
then determined.  
Drug Entrapment Study  
Hundred milligrams of the microparticles were placed in 
100 mL of phosphate buffer (pH 7.4) and allowed to 
disintegrate completely for 4 hr. The drug concentration 
in the buffer was analyzed at 353 nm using UV-visible 
spectrophotometer (Shimadzu 1800) and percent drug 
entrapment was calculated 
2
. 
% Drug entrapment =  
                             
                        
×100 
Percent mucoadhesion 
The mucoadhesive properties of the mucoadhesive 
microspheres were evaluated by in vitro wash-off test 
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[3].A 1x1 cm piece of stomach mucosa was mounted on 
to a glass slide with cyanoacrylate glue and rinsed with 
0.1N HCL. Fifty microspheres were spread on to it and 
kept in USP tablet disintegrating test apparatus 
containing the 900 ml of 0.1N HCL at 37± 0.5
o
C. 
Number of microspheres still adhering to tissue were 
calculated after 30 min, 1 hr and at the hourly intervals 
up to 6 hr. The studies were carried out in triplicate.   
% Mucoadhesion =       
                                                 
                        
×100 
 
Dissolution Study 
The release rate of clarithromycin microspheres was 
determined in a USP XXIII paddle type 2 dissolution 
apparatus. Weighed quantity of microspheres equivalent 
to 100 mg of clarithromycin was filled into a hard 
gelatin capsule (#2) and placed in the paddle of 
dissolution apparatus. The dissolution medium (900 mL) 
of SGF (pH 1.2) was used as dissolution medium. The 
dissolution fluid was maintained at 37±0.5 
0
C and 
rotation speed of 100 rpm.  The sample of 5 mL was 
withdrawn at the intervals 30 min of and was filtered 
through 0.25 μm membrane filter. The volume of the 
dissolution fluid was maintained by adding 5 ml of fresh 
dissolution fluid after each withdrawal. Samples were 
analyzed at 353 nm
2
.  
Statistical analysis  
In vitro drug release of CLA from CLAP3b was 
statistically treated by one-way analysis of variance, 
ANOVA followed by Dunnet’s test where P<0.05 was 
considered statistically significant.  
RESULTS AND DISCUSSION 
Microspheres were prepared by cation-induced 
controlled gelification of the polymer. The particle size, 
compressibility index, and angle of repose of the 
prepared microspheres was found in the range of 106 
±2.13to 180±0.78, 15.26±0.56 to 21.22±0.78, 
23.67±0.04 to 27.78±0.03.  The particles were found to 
be discrete, spherical and free flowing. The entrapment 
effieciency and percent mucoadhesion were found to be 
in the range of 70.25±0.02 to 62.24±0.02 and 40.1±1.2 
to 80.4±3.9 respectively.  The formulation CLA3b is 
opted as best formulation as it has optimum 
micromeritic properties, maximum entrapment 
efficiency and percent mucoadhesion.              
 
         Figure 1: SEM Photograph of formulation CLA3b 
 
Figure 2: Cumulative % drug release profile of CLA3b 
in simulated gastric fluid (pH 1.2) at 37°C ± 0.5°C. 
 
Table 1: Micromeritic properties, (%) drug entrapment and (%) mucoadhesion of the microspheres 
Formulation 
code 
Sodium 
alginate : 
pectin Ratio 
Average 
Particle size 
(µm) 
Compresibi-
lity index 
(%) 
Angle of 
repose in 
degree (
o
) 
Drug 
Entrapment 
(%) 
Mucoadhesion 
(%) 
CLA 1a 1:1 110±2.13 21.22±0.78 26.27±0.02 62.24±0.02 40.1±1.2 
CLA1b 1:2 108±1.43 19.67±0.79 27.78±0.03 65.67±0.04 45.2±0.01 
CLA1c 1:3 106±2.13 17.78±0.56 27.98±0.02 62.57±0.02 50.2±0.06 
CLA2a 2:1 144±0.34 17.56±0.57 25.98±0.04 67.46±0.01 50.4±0.04 
CLA2b 2:2 140±0.27 15.34±0.47 25.45±0.05 69.36±0.03 55.4±1.4 
CLA2c 2:3 139±0.45 15.26±0.56 24.67±0.03 66.58±0.02 65.5±0.08 
CLA3a 3:1 180±0.78 15.45±0.37 23.67±0.04 65.45±0.04 65.6±0.09 
CLA3b 3:2 179±0.68 16.67±0.25 25.01±0.06 70.25±0.02 80.4±3.9 
CLA3c 3:3 175±0.86 17.62±0.47 26.24±0.04 64.25±0.02 75.3±0.06 
 
 
 
0 
20 
40 
60 
80 
100 
1 2 3 4 5 6 7 8 9 10 11 
 C
u
m
u
la
ti
ve
 p
e
rc
e
n
t 
d
ru
g 
re
le
as
e
 
  Time in hours 
Jain et al                                                                                                                 Journal of Drug Delivery & Therapeutics. 2017; 7(7):81-83                       
ISSN: 2250-1177                                                                                [83]                                                                             CODEN (USA): JDDTAO 
CONCLUSION: 
Gastroretentive Clarithromycin microspheres were 
successfully prepared with significantly enhanced 
mucoadhesiveness and controlled release.  Such 
developed formulations could be furthers subjected for 
in vivo studies in future.  
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